TNF-α Increase in a Cohort of Depressive Patients

Table 1

Patient characteristics as well as BDI-II scores and TNF-α levels at time points 1 and 2 of both cohorts.

	Psychiatric day care unit ()		Psychotherapeutic unit ()
	Mean value	Standard deviation	Mean value	Standard deviation
Age (years)	43.38	14.01	36.89	10.58
Gender (m/f)	4/12	—	4/14	—
Moderate depressive episode	2	—	2	—
Severe depressive episode without psychotic symptoms	5	—	2	—
Recurrent depressive disorder, current episode moderate	5	—	9	—
Recurrent depressive disorder, current episode severe without psychotic symptoms	4	—	5	—
BMI (body mass index)	27.32	6.02	24.11	3.12
Treatment with antidepressants (y/n)	13/3	—	11/7	—
Treatment with antipsychotics (y/n)	1/16	—	0/18
Length of treatment (days)	45.86	17.63	60.35	13.33
BDI-II_T1 (score)	29.69	10.22	29.17	8.85
BDI-II_T2 (score)	22.60	8.98	15.94	13.41
TNF-α_T1 (pg/ml)	6.77	4.47	6.66	2.75
TNF-α_T2 (pg/ml)	6.57	4.87	50.39	11.60